COMMUNIQUÉS West-GlobeNewswire

Praxis Precision Medicines to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024

05/08/2024 - 22:01

BOSTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

05/08/2024 - 22:01

-More than 35 authorized treatment centers (ATCs) activated globally for CASGEVY™ and approximately 20 patients have had cells collected across all regions as of mid-July- -Clinical trials ongoing for next generation [...]

Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update

05/08/2024 - 22:01

Enrollment concluded in the Phase 2a proof-of-concept clinical trial evaluating SPR720 in nontuberculous mycobacterial pulmonary disease (NTM-PD) ; preliminary data expected in 4Q 2024 New SPR720 in-vitro resistance [...]

Akoya Biosciences Reports Second Quarter 2024 Financial Results

05/08/2024 - 22:00

MARLBOROUGH, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc . (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced its financial results for the second quarter ending June 30, 2024 [...]

Ultimovacs Announces Topline Data from FOCUS Phase II Trial of UV1 Combined with Pembrolizumab in Patients with Metastatic or Recurrent Head and Neck Cancer

05/08/2024 - 19:12

Adding Ultimovacs’ cancer vaccine UV1 to checkpoint inhibitor pembrolizumab did not meet primary or secondary endpoints in patients with metastatic or recurrent head and neck squamous cell carcinoma UV1 continues to [...]

Osteal Therapeutics Presents Positive Six-Month Results from the APEX Clinical Trial Program at the 34th Annual Musculoskeletal Infection Society Meeting

05/08/2024 - 18:28

The six-month efficacy endpoint of overall success showed a statistically significant improvement over standard of care, two-stage exchange arthroplasty DALLAS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Osteal Therapeutics, Inc [...]

Transparency Notification from Shareholders

05/08/2024 - 18:00

PRESS RELEASE REGULATED INFORMATION 5 August 2024, 06 pm CEST Transparency Notification from Shareholders Ghent, Belgium – 5 August 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana [...]

Ipsen - July 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

05/08/2024 - 18:00

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]

Ipsen - Juillet 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

05/08/2024 - 18:00

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]

RAMSAY SANTE : Non audited consolidated financial statements for FY24

05/08/2024 - 17:35

PRESS RELEASE Paris, 5 August 2024 Ramsay Health Care publishes certain financial information about its non audited consolidated financial statements for FY24 Ramsay Santé relays the press release (attached) issued [...]

RAMSAY SANTE : Eléments financiers consolidés non audités à fin juin 2024

05/08/2024 - 17:35

COMMUNIQUÉ DE PRESSE Paris, le 5 août 2024 Ramsay Health Care publie certains éléments financiers consolidés non audités à fin juin 2024 Ramsay Santé relaie le communiqué de presse (ci-joint) publié ce jour par Ramsay [...]

Report: At $686,000 Orthopedic Surgeons Earn The Highest Physician Starting Salary

05/08/2024 - 16:00

Pediatricians Are at the Low End at $244,000 DALLAS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Orthopedic surgeons are offered the highest average starting salary among physicians at $686,000, while pediatricians are at the low [...]

Baylor Genetics and Baylor College of Medicine Announce New Lab Agreement with Shared Commitment to Innovation and Rapid Implementation to get Critical Testing to Patients

05/08/2024 - 16:00

New lab currently provides Whole Transcriptomic RNA Sequencing for the Undiagnosed Diseases Network’s nationwide clinical institutions HOUSTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics , a joint venture [...]

OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024

05/08/2024 - 15:08

PRESS RELEASE OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024 Oxford, United Kingdom – 5 th August 2024 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying [...]

Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson

05/08/2024 - 15:01

AUSTIN, Texas, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today reflected on the passing of long-time board member Sanford Robertson. We are profoundly saddened by the passing of our dear [...]

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

05/08/2024 - 15:00

Market research data shows interest in additional glucose monitoring options for people with diabetes who use insulin Rutherford, NJ, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or [...]

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility

05/08/2024 - 15:00

Proceeds to be used for OneRF commercialization activities and to bridge the Company to the close of a potential distribution arrangement with a strategic partner currently in the diligence process EDEN PRAIRIE, Minn., [...]

NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024

05/08/2024 - 15:00

CARMEL, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]

Dror Ortho-Design, Inc. Launches ZSMILE User Experience Trial

05/08/2024 - 15:00

JERUSALEM, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's [...]